A comprehensive view of Immune System Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Healthcare professionals rank AbbVie as top player in immunology, despite competition from Pfizer and J&J, according to ZoomRx analysis; AbbVie scored highest in innovation and patient centricity, while Pfizer and J&J ranked second and third respectively
Published: April 19, 2024 by FiercePharma
AstraZeneca to present new data on its vaccine & immune therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases; the company will showcase 19 abstracts
Published: April 18, 2024 by PharmaBiz (India)
Sanofi's frexalimab shows high efficacy in 48-week Phase 2 trial for multiple sclerosis, with an annualized relapse rate of 0.04 for high-dose variants; Phase 3 studies have begun for both relapsing and non-relapsing secondary progressive MS
Published: April 17, 2024 by Sanofi SA
Shah Capital nominates two highly qualified independent director candidates for Novavax
Published: April 15, 2024 by GlobeNewswire
GlobalData: Adaptogens on cusp of becoming mainstream ingredients in non-alcoholic drinks; these functional ingredients claim to boost immunity, ease anxiety and relieve stress, which are among major consumer focus areas post-pandemic
Published: April 10, 2024 by ForeignAffairs.co.nz

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count